Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.250
+0.160 (7.66%)
Apr 29, 2025, 1:39 PM EDT - Market open
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $174.32 million as of April 29, 2025. Its market cap has decreased by -4.19% in one year.
Market Cap
174.32M
Enterprise Value
117.68M
1-Year Change
-4.19%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $174.32M, an increase of 39.21%. That is a compound annual growth rate of 2.79%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |